UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 84 filers reported holding UROGEN PHARMA LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,013,071 | +35.4% | 857,464 | 0.0% | 0.25% | +49.7% |
| Q2 2023 | $8,874,752 | +12.0% | 857,464 | 0.0% | 0.17% | +2.4% |
| Q1 2023 | $7,922,967 | +4.2% | 857,464 | 0.0% | 0.16% | +6.5% |
| Q4 2022 | $7,605,706 | +6.6% | 857,464 | 0.0% | 0.16% | -5.5% |
| Q3 2022 | $7,134,000 | +1.6% | 857,464 | 0.0% | 0.16% | -9.4% |
| Q2 2022 | $7,023,000 | -6.0% | 857,464 | 0.0% | 0.18% | +16.8% |
| Q1 2022 | $7,469,000 | -8.4% | 857,464 | 0.0% | 0.16% | +30.3% |
| Q4 2021 | $8,154,000 | -43.5% | 857,464 | 0.0% | 0.12% | -45.4% |
| Q3 2021 | $14,423,000 | – | 857,464 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |